Darunavir
Prezista (darunavir) is a small molecule pharmaceutical. Darunavir was first approved as Prezista on 2006-06-23. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Prezista's patent is valid until 2026-12-26 (FDA).
| Trade Name | Prezista |
|---|---|
| Common Name | Darunavir |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: HIV protease inhibitors (saquinavir type) |
